Salesforce, Inc.

Analyst Ratings Synthesis

The supplied consensus is Buy across 42 analysts, with a mean target of $271. The target data is internally inconsistent: it lists both the low and high at $228, so a defensible target spread or meaningful clustering cannot be calculated from those figures. Guggenheim is explicitly the least bullish identifiable analyst, having raised its target to $228 on July 1 from a previously Neutral stance; no most-bullish analyst is named in the supplied evidence. No rating or target revisions during the past week are documented. The substantive disagreement is whether Salesforce’s improving profitability and AI initiatives can restore durable growth, versus concerns that software disruption, weak chart momentum, and uncertain AI monetization undermine the valuation.

• Can Klaviyo (KVYO) Justify Its Valuation After Its CRM Overhaul And MNTN Tie Up?
• Salesforce’s stock has been riding a wave of AI optimism. Here’s what Wall Street wants to see next.
• Adobe vs. Salesforce: Which Software Stock Is a Better Buy in 2026?
• Is Salesforce Stock Cheap Because Software Is Dying?
• Is Salesforce Stock Cheap Because Software Is Dying?